Efficacy and Safety of Topical Metformin vs Kligman Formula in the Treatment of Melasma: A Split-Face Study
Journal of Drugs in Dermatology · 01.05.2026 · 25 (5) · 435-439
DOI: 10.36849/jdd.9193 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Journal of Drugs in Dermatology, online erschienen am 01.04.2026. Verfasst von Eman Ayesha und 12 weiteren Autor:innen. Hauptthemen laut MEDLINE: Melanosis, Skin Cream, Metformin, Dermatologic Agents.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Ayesha, E., Hanif, S., Agaiby, S., Greco, M. E., Tchack, M., Butt, H. S., Hamadani, A., Shaukat, R., Akbar, T., Musolff, N., Rafiq, B., Rao, B., & Nabi, H. (2026). Efficacy and Safety of Topical Metformin vs Kligman Formula in the Treatment of Melasma: A Split-Face Study. Journal of Drugs in Dermatology, 25(5), 435-439. https://doi.org/10.36849/jdd.9193
Vancouver
Ayesha E, Hanif S, Agaiby S, Greco ME, Tchack M, Butt HS, et al. Efficacy and Safety of Topical Metformin vs Kligman Formula in the Treatment of Melasma: A Split-Face Study. Journal of Drugs in Dermatology. 2026;25(5):435-439. doi:10.36849/jdd.9193
BibTeX
@article{Ayesha2026,
author = {Ayesha, Eman and Hanif, Sumera and Agaiby, Sandy and Greco, Maria Elisabetta and Tchack, Madeline and Butt, Hooriya Shafiq and Hamadani, Aliza and Shaukat, Rabia and Akbar, Talat and Musolff, Noah and Rafiq, Bassem and Rao, Babar and Nabi, Haroon},
title = {Efficacy and Safety of Topical Metformin vs Kligman Formula in the Treatment of Melasma: A Split-Face Study},
journal = {Journal of Drugs in Dermatology},
year = {2026},
volume = {25},
number = {5},
pages = {435--439},
doi = {10.36849/jdd.9193}
}
EUVIMED